N@N

WEALTHMAKERS.COM Issues Bullish Research Reports on PSTI, SNSS, SVM, TWO

^{Published on 2013-04-10 08:30:56 - WealthMakers}
 

<div>April 10, 2013 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Pluristem Therapeutics Inc (NASDAQ:PSTI), Sunesis Pharmaceuticals Inc (NASDAQ:SNSS), Silvercorp Metals Inc (NYSE:SVM), Twoco Petroleums Ltd (NYSE:TWO)

<p>Click here to download each report:</p>

Pluristem Therapeutics Inc (NASDAQ:PSTI): http://www.wealthmakers.com/ireport/23580 Sunesis Pharmaceuticals Inc (NASDAQ:SNSS): http://www.wealthmakers.com/ireport/23587 Silvercorp Metals Inc (NYSE:SVM): http://www.wealthmakers.com/ireport/23583 Twoco Petroleums Ltd (NYSE:TWO): http://www.wealthmakers.com/ireport/23498

<p>WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.</p>

Click here to LIKE us on Facebook:

<p>http://www.facebook.com/pages/WealthMakers-Ltd/165424826916060 </p>

Click here to FOLLOW us on Twitter:

<p>http://www.twitter.com/WealthMakersLtd </p>

Click here to access WealthMakers technology:

<p>http://www.wealthmakers.com/signup.html </p>

Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited.

<p>To learn more click here: http://www.buyins.com/woprbrochure.pdf

WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf</p>

Pluristem Therapeutics Inc (NASDAQ:PSTI) - Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company s products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.

<p>Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) - Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company s principal product includes Vosaroxin, an anti-cancer quinolone derivative for the treatment of acute myeloid leukemia (AML). It is conducting various clinical trials of Vosaroxin, including Phase II clinical trial, known as VALOR trial in combination with cytarabine for the treatment of patients with relapsed or refractory AML; and a Phase II clinical trial, known as REVEAL-1 in previously untreated patients of age 60 years or older, as well as completed a Phase II single-agent trial of Vosaroxin in patients with platinum-resistant ovarian cancer. In addition, the company is conducting a Phase II/III trial, known as the Less Intensive 1 in patients older than 60 years with AML or high-risk myelodysplastic syndrome. It has a license agreement with Dainippon Sumitomo Pharma Co., Ltd. for the development and commercialization of Vosaroxin; a collaboration agreement with Millennium for the development of pan-Raf kinase inhibitor and one additional undisclosed kinase inhibitor program in oncology; and a collaboration agreement with Biogen Idec, Inc. to discover, develop, and commercialize small molecule inhibitors of a preclinical kinase inhibitor program in immunology. The company formerly known as, Mosaic Pharmaceuticals, Inc., was founded in 1998 and is headquartered in South San Francisco, California.</p>

Silvercorp Metals Inc (NYSE:SVM) - Silvercorp Metals Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and mining of precious and base metal properties in China and Canada. It operates four silver-lead-zinc mines comprising the Ying, TLP, HPG, and LM mines located in the Ying Mining District in the Henan Province of China. The company also holds interests in the XBG silver-gold-lead-zinc mine with a mining permit covering 26.36 square kilometers (km2); and the XHP silver-gold-lead-zinc mine comprising a 14 km2 mining permit located in the Ying Mining District in Henan Province of China. In addition, it engages in operating the BYP gold-lead-zinc project in Hunan Province, and mining at the GC silver-lead-zinc project in Guangdong Province in China. The company was formerly known as SKN Resources Ltd. and changed its name to Silvercorp Metals Inc. in May 2005. Silvercorp Metals Inc. is headquartered in Vancouver, Canada.

<p>Twoco Petroleums Ltd (NYSE:TWO) - Two Harbors Investment Corp. operates as a real estate investment trust (REIT) that focuses on investing in, financing, and managing residential mortgage-backed securities (RMBS), residential mortgage loans, residential real properties, and other financial assets. Its target assets include agency RMBS collateralized by fixed rate mortgage loans, adjustable rate mortgage loans, hybrid mortgage loans, or derivatives; non-agency RMBS collateralized by prime mortgage loans, Alt-A mortgage loans, pay-option ARM mortgage loans, and subprime mortgage loans; nonconforming residential mortgage loans; and single and multi-family residential properties, as well as asset-backed securities and hedging transactions that produce non-qualifying income for purposes of the REIT gross income tests. The company qualifies as a REIT for federal income tax purposes. As a REIT, the company would not be subject to federal income tax, if it distributes at least 90% of net taxable income to its stockholders. PRCM Advisers LLC operates as the manager of Two Harbors Investment Corp. Two Harbors Investment Corp. was founded in 2007 and is headquartered in Minnetonka, Minnesota.</p>

About WEALTHMAKERS

<p>Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction!</p>

Strategies include:

<p>EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports.</p>

FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.

<p>GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.</p>

GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.

<p>PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.</p>

EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.

<p>RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.</p>

SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.

<p>SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.</p>

VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.

<p>INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.</p>

DISCLAIMER:

<p>WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures. </p>

Contact:

WEALTHMAKERS 1-516-858-1113 tom@wealthmakers.com www.wealthmakers.com

</div>